Director Akkaraju Srinivas Makes Nearly $10M Open Market Purchase in ALMS
ALMS has more than doubled off its 52-week low of $2.76 on elevated volume (1.9× avg).
Summary
A director of Alumis Inc. made a substantial open market purchase of the company's common stock, signaling strong confidence.
Key Events · Ownership and Investor Activity · ALMS
-
Significant Insider Purchase
Director Akkaraju Srinivas, through Samsara Opportunity Fund, L.P., purchased 588,235 shares of Alumis Inc. common stock for a total value of $9,999,995.
-
Strong Vote of Confidence
This substantial open market transaction by a director signals strong conviction in the company's valuation and future performance.
-
Purchase Price Context
The shares were acquired at $17.00 each on January 9, 2026, which is below the current trading price of $22.56.
Analysis · ALMS · Life Sciences
Srinivas Akkaraju, a director of Alumis Inc., executed a significant open market purchase of nearly $10 million worth of common stock through Samsara Opportunity Fund, L.P. This substantial investment by an insider, particularly a director, indicates strong conviction in the company's future prospects. The purchase was made at $17.00 per share on January 9, 2026, which is below the current stock price of $22.56. Such a large insider buy can be a positive signal to the market, implying that those closest to the company believe the stock has significant upside potential.
At the time of this filing, ALMS was trading at $22.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.8B. The 52-week trading range was $2.76 to $23.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.